Sofosbuvir/Velpatasvir 400 mg/100 mg Film coated Tablet

Sofosbuvir/Velpatasvir 400 mg/100 mg Film coated Tablet
Product Description

Description: Oral fixed-dose combination tablet containing sofosbuvir and velpatasvir, used for the treatment of chronic hepatitis C virus (HCV) infection across multiple genotypes.
Therapeutic Category: Antiviral / Direct-Acting Antiviral (DAA)

Mechanism of Action (MOA): 
Sofosbuvir inhibits the HCV NS5B RNA-dependent RNA polymerase, while velpatasvir inhibits the NS5A protein, both essential for viral replication.

This helps:
• Block replication of the hepatitis C virus
• Reduce viral load effectively
• Achieve high cure rates across HCV genotypes
• Improve liver function and prevent disease progression 

Swasthya Healthcare Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

Swasthya Healthcare Private Limited

  • Country/Region:
    India
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    100 - 249
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

More Products from Swasthya Healthcare Private Limited (31)

  • Tirzepatide Injection (Pre-filled Syringe)

    Product Tirzepatide Injection (Pre-filled Syringe)

    Description: Sterile, ready-to-use pre-filled syringe containing tirzepatide, designed for subcutaneous administration. It is a long-acting injectable therapy used for glycemic control and metabolic management.

    Therapeutic Category: Antidiabetic Agent / Dual GIP &am...
  • Iopamidol Injection USP

    Product Iopamidol Injection USP

    Description: Sterile, non-ionic, water-soluble iodinated contrast medium for intravenous or intra-arterial administration. Used to enhance radiographic imaging during diagnostic procedures.


    Therapeutic Category: Radiographic Contrast Agent / Diagnostic Imaging


    Mechanism of...
  • Semaglutide Injection 0.50 mg/0.5 ml

    Product Semaglutide Injection 0.50 mg/0.5 ml

    Description: Sterile injectable formulation of semaglutide, a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. Designed for sustained glycemic control with once-weekly dosing. Primarily used in the management of type 2 diabetes mellitus and, in some cases, for weight management.

    T...
  • Goserelin Acetate PFS 3.6 mg

    Product Goserelin Acetate PFS 3.6 mg

    Description: Sterile depot formulation of goserelin acetate supplied in a pre-filled syringe for subcutaneous implantation. It is a long-acting gonadotropin-releasing hormone (GnRH) agonist designed for sustained suppression of sex hormone production with extended-release dosing, typically administered on...
  • Human Normal Albumin 5%

    Product Human Normal Albumin 5%

    Description: Sterile intravenous solution of human normal albumin at 5% concentration, derived from pooled human plasma. It is an iso-oncotic colloid solution used to restore and maintain circulating blood volume.

    Therapeutic Category: Plasma Volume Expander / Colloid

    Mechanism of...
  • Goserelin Acetate Injection 3.6 mg/vial

    Product Goserelin Acetate Injection 3.6 mg/vial

    Description: Sterile injectable depot formulation of goserelin acetate, a synthetic analogue of gonadotropin-releasing hormone (GnRH). Designed for sustained release to provide long-term hormonal suppression. Primarily used in the treatment of hormone-sensitive cancers and certain gynecological conditions....
  • Pegaspargase injection 3750 IU/5 ml

    Product Pegaspargase injection 3750 IU/5 ml

    Description: Sterile injectable formulation of pegaspargase, a pegylated form of the enzyme L-asparaginase. Designed for prolonged activity and reduced immunogenicity. Primarily used in the treatment of certain leukemias.

    Therapeutic Category: Antineoplastic / Enzym...
  • Trastuzumab Injection 440 mg

    Product Trastuzumab Injection 440 mg

    Description: Sterile injectable formulation containing trastuzumab, a monoclonal antibody used in the treatment of HER2-positive cancers, particularly breast and gastric cancers. Administered intravenously or subcutaneously under medical supervision.

    Therapeu...
  • Leuprolide Depot Injection 22.5 mg

    Product Leuprolide Depot Injection 22.5 mg

    Description: Sterile long-acting depot formulation of leuprolide acetate for intramuscular or subcutaneous administration. Designed for sustained release over weeks or months. Commonly used in hormone-dependent conditions.Therapeutic Category: GnRH Agonist / Hormonal Therapy
    Mechanism of...
  • Iohexol Injection USP

    Product Iohexol Injection USP

    Description: Sterile, non-ionic, water-soluble iodinated contrast medium used for intravenous or intra-arterial administration. It is widely used to enhance contrast in diagnostic imaging procedures.

    Therapeutic Category: Radiographic Contrast Agent / Diagnostic Ima...
  • Human Normal Immunoglobulin for Intravenous Use B.P 5%

    Product Human Normal Immunoglobulin for Intravenous Use B.P 5%

     
    Description: Sterile intravenous solution containing purified immunoglobulin G (IgG) derived from pooled human plasma. It undergoes rigorous screening, purification, and viral inactivation processes to ensure safety. Used to support or modulate the immune system.
    ...
  • Octreotide Injectable Solution 100 mcg/ml

    Product Octreotide Injectable Solution 100 mcg/ml

    Description: Sterile injectable solution containing octreotide, a synthetic analogue of the natural hormone somatostatin. Administered subcutaneously or intravenously for various hormone-related conditions.

    Therapeutic Category: Somatostatin Analogue / Hormon...

Swasthya Healthcare Private Limited resources (3)